ArticleNeuropsychology2026
Digital maze test reveals cognitive performance patterns associated with amyloid-β and tau.
Article in Neuropsychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveDigital cognitive tools provide novel ways to examine subtle cognitive processes not captured with traditional measures. This is particularly useful in examining subtle cognitive changes in early Alzheimer's disease (AD) stages. Here, we evaluate a digital maze test and its association to AD biomarkers in a largely cognitively unimpaired sample.
methodA total of 221 participants in the Harvard Aging Brain Study and affiliated studies completed a digital maze test, and neuropsychological battery including the trail making test. Cortical Amyloid-β and tau burden were visualized with C¹¹Pittsburgh compound B (PiB), and [¹⁸ F]Flortaucipir. Latent patterns among maze features were explored with principal component analysis and least absolute shrinkage and selection operator regression was applied to evaluate their associations with PiB and [¹⁸ F]Flortaucipir. Multiple regression models explored both maze features and trail making test variables in models predicting AD biomarkers.
resultsPrincipal component analysis results revealed maze performance is characterized by separate speed, path following, and impulsivity/planning components. Least absolute shrinkage and selection operator regression models revealed longer time duration (95% CI [5.31, 25.31]), greater pen-off-page time (CI [5.42, 16.81]), and pen stroke count (CI [.004, 0.021]) were associated with higher PiB. Higher pen stroke count (CI [0.003, 0.010]), and time deviating from the correct path (CI [0.0003, 0.002]) were associated with [¹⁸ F]Flortaucipir. In multiple regression models, specific maze features remained significant predictors of PiB beyond trail making test performance.
conclusionUnique, digitally captured maze features are associated with AD pathology beyond what is seen by a traditional executive measure. This easy to administer, time-efficient digital tool provides unique information about amyloid and tau-related cognitive change. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.